Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis

CompletedOBSERVATIONAL
Enrollment

943

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

November 8, 2019

Study Completion Date

January 27, 2020

Conditions
Multiple Myeloma
Interventions
OTHER

No Intervention

As it was an observational study, no intervention was administered.

Trial Locations (17)

40110-150

Centro de Hematologia e Oncologia (CEHON), Salvador

41253-190

Hospital Sao Rafael, Salvador

74605-020

Hospital das Clinicas da UFG, Goiânia

30130-100

Hospital das Clinicas da UFMG, Belo Horizonte

36036-330

Fundacao IMEPEN, Juiz de Fora

78055-000

Clinica de Tratamento e Pesquisa em Hematologia LTDA., Cuiabá

80060-900

Hospital das Clinicas da UFPR, Curitiba

80810-050

CIONC - Centro Integrado de Oncologia de Curitiba, Curitiba

21941-590

Universidade Federal do Rio de Janeiro, Rio de Janeiro

99010-080

Hospital Sao Vicente de Paulo, Passo Fundo

90035-903

Hospital de Clinicas de Porto Alegre, Porto Alegre

88034-000

Centro de Pesquisas Oncologicas (CEPON), Florianópolis

17210-080

Hospital Amaral Carvalho, Jaú

04029-000

Hospital do Servidor Publico de SP, São Paulo

04537-081

Clinica Sao Germano, São Paulo

05403-000

Hospital das Clinicas da FMUSP, São Paulo

08270-060

Casa de Saude Santa Marcelina, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03506386 - Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis | Biotech Hunter | Biotech Hunter